Eirene Kontopoulos manages the investment giant Fidelity's $2.5 billion biotech fund. The fund includes stakes in pharma and biotech companies like AbbVie, Vertex and Amgen. She told Business Insider that with hundreds of biotech companies in play, a "mental checklist" helps her narrow down which to invest in. Kontopoulos came to the job from a PhD in neuroscience at Harvard, and says that background also guides her investment strategy. Visit Business Insider's homepage for more stories. In the high-risk, high-reward field of biotech, hundreds of companies are racing to develop the next up-and-coming new medicine.